Literature DB >> 2005401

Endotoxin-induced cytokine gene expression in vivo. III. IL-6 mRNA and serum protein expression and the in vivo hematologic effects of IL-6.

T R Ulich1, K Z Guo, D Remick, J del Castillo, S M Yin.   

Abstract

Endotoxin (LPS) at sublethal doses injected i.v. into rats was found to induce IL-6 mRNA expression peaking at 1 to 2 h in whole organ RNA preparations of the spleen, liver, lung, bowel, and kidney. IL-6 serum protein levels also peaked at 2 h. TNF and IL-1, generally considered to be among the most rapidly released cytokines, also induced IL-6 expression. IL-6 in turn inhibited TNF and IL-1 expression, suggesting that IL-6 may be part of a negative feedback mechanism in the cytokine cascade. Dexamethasone down-regulated and Corynebacterium parvum up-regulated IL-6 expression, although the possibility cannot be excluded that these immunomodulating factors may in part have exerted their effects indirectly via the up- and down-regulation of TNF and IL-1. IL-6 injected i.v. at a pathophysiologically relevant dose caused a peripheral neutrophilia and mild myeloproliferative effect in the bone marrow.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2005401

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  42 in total

Review 1.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

2.  Deletion of tristetraprolin caused spontaneous reactive granulopoiesis by a non-cell-autonomous mechanism without disturbing long-term hematopoietic stem cell quiescence.

Authors:  Ian M Kaplan; Sebastien Morisot; Diane Heiser; Wen-Chih Cheng; Min Jung Kim; Curt I Civin
Journal:  J Immunol       Date:  2011-01-26       Impact factor: 5.422

3.  Intratracheal administration of endotoxin and cytokines: VIII. LPS induces E-selectin expression; anti-E-selectin and soluble E-selectin inhibit acute inflammation.

Authors:  T R Ulich; S C Howard; D G Remick; E S Yi; T Collins; K Guo; S Yin; J L Keene; J J Schmuke; C N Steininger
Journal:  Inflammation       Date:  1994-08       Impact factor: 4.092

4.  IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses.

Authors:  Z Xing; J Gauldie; G Cox; H Baumann; M Jordana; X F Lei; M K Achong
Journal:  J Clin Invest       Date:  1998-01-15       Impact factor: 14.808

5.  Epithelial cells respond to proteolytic and non-proteolytic detachment by enhancing interleukin-6 responses.

Authors:  Tabbi L Miller; Dennis W McGee
Journal:  Immunology       Date:  2002-01       Impact factor: 7.397

6.  Tumor necrosis factor-alpha, interleukin-6, and interleukin-8 secretion and the acute-phase response in patients with bacterial and tuberculous osteomyelitis.

Authors:  C A Evans; J Jellis; S P Hughes; D G Remick; J S Friedland
Journal:  J Infect Dis       Date:  1998-06       Impact factor: 5.226

7.  Interleukin-6, but not tumour necrosis factor-alpha, increases lipogenesis in rat hepatocyte primary cultures.

Authors:  E P Brass; W H Vetter
Journal:  Biochem J       Date:  1994-07-01       Impact factor: 3.857

8.  Glomerular expression of interleukin-1 receptor antagonist and interleukin-1 beta genes in antibody-mediated glomerulonephritis.

Authors:  F W Tam; J Smith; S J Cashman; Y Wang; E M Thompson; A J Rees
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

9.  Endotoxin-induced cytokine gene expression in vivo. IV. Expression of interleukin-1 alpha/beta and interleukin-1 receptor antagonist mRNA during endotoxemia and during endotoxin-initiated local acute inflammation.

Authors:  T R Ulich; K Guo; S Yin; J del Castillo; E S Yi; R C Thompson; S P Eisenberg
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

10.  Effect of postponed treatment with an anti-tumour necrosis factor (TNF) F(ab')2 fragment on endotoxin-induced cytokine and neutrophil responses in chimpanzees.

Authors:  T van der Poll; M Levi; H ten Cate; J Jansen; B J Biemond; B L Haagmans; A Eerenberg; S J van Deventer; C E Hack; J W ten Cate
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.